GJ
Galante Joseph C Director
Board M
US US · SEC (Form 4)
€3,997
▲ Purchases (13 ops.)
Explore the detailed record of transactions filed by Galante Joseph C, Director. Insider active across 2 companies, notably Cumberland Pharmaceuticals INC. Aggregated, 17 filings have been logged. Total volume traded: €4k. The latest transaction was disclosed on 1 June 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations 17 total
€146 76 shares @ €1.9241 0.0002% mcap 1.2% of flow
Common Stock
SEC:0001209191-22-040094:0 · 1 Jun 2022
Ideal exit: 26 Feb 2023 (T+270) €142 61 shares @ €2.3313 0.0002% mcap 1.2% of flow
Common Stock
SEC:0001209191-22-035994:0 · 2 May 2022
Ideal exit: 27 Jan 2023 (T+270) €140 56 shares @ €2.5044 0.0002% mcap 1.2% of flow
Common Stock
SEC:0001209191-22-027646:0 · 14 Apr 2022
Ideal exit: 9 Jan 2023 (T+270) €2,361 1,000 shares @ €2.3611 0.0029% mcap 20.1% of flow
Common Stock
SEC:0001209191-22-026138:0 · 16 Mar 2022
€18,115 201 shares @ €90.1219 100.0% of flow
PNFP Common Stock
SEC:0001567619-22-006185:0 · 1 Mar 2022
€328 142 shares @ €2.3104 0.0004% mcap 7.3% of flow
Common Stock
SEC:0001209191-21-067899 · 1 Nov 2021
Ideal exit: 29 Jul 2022 (T+270) €328 142 shares @ €2.3104 0.0004% mcap 2.8% of flow
Common Stock
SEC:0001209191-21-067899:0 · 1 Nov 2021
Ideal exit: 29 Jul 2022 (T+270) €330 142 shares @ €2.3241 0.0004% mcap 7.4% of flow
Common Stock
SEC:0001209191-21-063235 · 1 Oct 2021
Ideal exit: 28 Jun 2022 (T+270) €330 142 shares @ €2.3241 0.0004% mcap 2.8% of flow
Common Stock
SEC:0001209191-21-063235:0 · 1 Oct 2021
Ideal exit: 28 Jun 2022 (T+270) €345 142 shares @ €2.4322 0.0004% mcap 7.7% of flow
Common Stock
SEC:0001209191-21-058530 · 1 Sept 2021
Ideal exit: 29 May 2022 (T+270) €345 142 shares @ €2.4322 0.0004% mcap 2.9% of flow
Common Stock
SEC:0001209191-21-058530:0 · 1 Sept 2021
Ideal exit: 29 May 2022 (T+270) €399 142 shares @ €2.8127 0.0005% mcap 8.9% of flow
Common Stock
SEC:0001209191-21-055485 · 2 Aug 2021
Ideal exit: 29 Apr 2022 (T+270) €399 142 shares @ €2.8127 0.0005% mcap 3.4% of flow
Common Stock
SEC:0001209191-21-055485:0 · 2 Aug 2021
Ideal exit: 29 Apr 2022 (T+270) €381 142 shares @ €2.684 0.0005% mcap 8.5% of flow
Common Stock
SEC:0001209191-21-051441 · 8 Jul 2021
Ideal exit: 4 Apr 2022 (T+270) €381 142 shares @ €2.684 0.0005% mcap 3.2% of flow
Common Stock
SEC:0001209191-21-051441:0 · 8 Jul 2021
Ideal exit: 4 Apr 2022 (T+270) €2,706 1,000 shares @ €2.7055 0.0033% mcap 23.0% of flow
Common Stock
SEC:0001209191-21-039932:0 · 17 Mar 2021
€2,706 1,000 shares @ €2.7055 0.0033% mcap 60.3% of flow
Common Stock
SEC:0001209191-21-039932 · 17 Mar 2021
About Galante Joseph C Joseph C. Galante is an executive at Cumberland Pharmaceuticals Inc.